Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daccak Munzer. (1997) Angle of His in the Cardioesophageal Junction: Is It a Primordial Factor in Reflux Esophagitis?. Scandinavian Journal of Gastroenterology 32:8, pages 847-847.
Read now
Read now
Articles from other publishers (38)
Alexandra Argyrou, Evangelia Legaki, Christos Koutserimpas, Maria Gazouli, Ioannis Papaconstantinou, George Gkiokas & George Karamanolis. (2019) Polymorphisms of the BARX1 and ADAMTS17 Locus Genes in Individuals With Gastroesophageal Reflux Disease. Journal of Neurogastroenterology and Motility 25:3, pages 436-441.
Crossref
Crossref
Alexandra Argyrou, Evangelia Legaki, Christos Koutserimpas, Maria Gazouli, Ioannis Papaconstantinou, George Gkiokas & George Karamanolis. (2018) Risk factors for gastroesophageal reflux disease and analysis of genetic contributors. World Journal of Clinical Cases 6:8, pages 176-182.
Crossref
Crossref
F. Zerbib & J.-P. Galmiche. (2011) Traitement du reflux gastro-œsophagien de l'adulte. EMC - Gastro-entérologie 6:1, pages 1-12.
Crossref
Crossref
Naoki Chiba & M Brian Fennerty. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
17
61
.
Mohammad Yaghoobi, Sara Padol, Yuhong Yuan & Richard H. Hunt. (2010) Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. European Journal of Gastroenterology & Hepatology 22:5, pages 583-590.
Crossref
Crossref
O. CHASSANY, G. HOLTMANN, J. MALAGELADA, U. GEBAUER, H. DOERFLER & K. DEVAULT. (2008) Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 27:11, pages 1053-1070.
Crossref
Crossref
Irvin M. Modlin & Steven F. Moss. (2008) Symptom Evaluation in Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 42:5, pages 558-563.
Crossref
Crossref
Vasundhara Tolia. (2008) Pantoprazole in pediatric gastroesophageal reflux disease. Pediatric Health 2:2, pages 135-140.
Crossref
Crossref
Francesco Arena, Carmelo Romeo, Sergio Baldari, Salvatore Arena, Pietro Antonuccio, Alfredo Campennì, Biagio Zuccarello & Giuseppe Romeo. (2008) Gastrointestinal sequelae in survivors of congenital diaphragmatic hernia. Pediatrics International 50:1, pages 76-80.
Crossref
Crossref
Siavosh Nasseri-Moghaddam, Hadi Razjouyan, Seyed Maysam Alimohamadi, Mansoureh Mamarabadi, Mohamad-Hamed Ghotbi, Pardis Mostajabi, Amir-Ali Sohrabpour, Masoud Sotoudeh, Behnoush Abedi, Azadeh Mofid, Mehdi Nouraie, Shahnaz Tofangchiha & Reza Malekzadeh. (2007) Prospective Acid Reflux Study of Iran (PARSI): Methodology and study design. BMC Gastroenterology 7:1.
Crossref
Crossref
B. Tierney, A. Iqbal, M. Haider & C. Filipi. (2007) Effects of prior endoluminal gastroplication on subsequent laparoscopic Nissen fundoplication. Surgical Endoscopy 21:2, pages 321-323.
Crossref
Crossref
P. W. Dettmar, J. Sykes, S. L. Little & J. Bryan. (2006) Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes. International Journal of Clinical Practice 60:3, pages 275-283.
Crossref
Crossref
J. Lacau St Guily, S. Périé, M. Bruel, B. Roubeau, B. Susini & C. Gaillard. (2006) Troubles de la déglutition de l'adulte. Prise en charge diagnostique et thérapeutique. EMC - Gastro-entérologie 1:2, pages 1-17.
Crossref
Crossref
Ernst Eypasch, Edmund A.M. Neugebauer, F. Fischer, Hans Troidl, A.L. Blum, D. Collet, A. Cuschieri, B. Dallemagne, H. Feussner, K.-H. Fuchs, H. Glise, C.K. Kum, T. Lerut, L. Lundell, H.E. Myrvold, A. Peracchia, H. Petersen & J.J.B. van Lanschot. 2006. EAES Guidelines for Endoscopic Surgery. EAES Guidelines for Endoscopic Surgery
97
124
.
F. Pace & G. Bianchi Porro. 2006. Gastroesophageal Reflux Disease. Gastroesophageal Reflux Disease
1
11
.
J.F. Bretagne, J.-F. Rey, A. Caekaert & P. Barthélemy. (2005) Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: A prospective observational study. Digestive and Liver Disease 37:8, pages 566-570.
Crossref
Crossref
J. Lacau St Guily, S. Périé, M. Bruel, B. Roubeau, B. Susini & C. Gaillard. (2005) Troubles de la déglutition de l'adulte. Prise en charge diagnostique et thérapeutique. EMC - Oto-rhino-laryngologie 2:1, pages 1-25.
Crossref
Crossref
J. Lacau St Guily, S. Périé, M. Bruel, B. Roubeau, B. Susini & C. Gaillard. (2005) Trastornos de la deglución del adulto. Diagnóstico y tratamiento. EMC - Otorrinolaringología 34:3, pages 1-19.
Crossref
Crossref
Naoki Chiba. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
13
54
.
K. D. Bardhan, V. Stanghellini, D. Armstrong, P. Berghöfer, G. Gatz & H. Mönnikes. (2004) International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 20:8, pages 891-898.
Crossref
Crossref
M Kulig, M Nocon, M Vieth, A Leodolter, D Jaspersen, J Labenz, W Meyer-Sabellek, M Stolte, T Lind, P Malfertheiner & S.N Willich. (2004) Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. Journal of Clinical Epidemiology 57:6, pages 580-589.
Crossref
Crossref
Irvin M Modlin, Steven F Moss, Mark Kidd & Kevin D Lye. (2004) Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 38:5, pages 390-402.
Crossref
Crossref
V. Stanghellini, D. Armstrong, H. Mönnikes & K. D. Bardhan. (2004) Do we need a new gastro‐oesophageal reflux disease questionnaire?. Alimentary Pharmacology & Therapeutics 19:5, pages 463-479.
Crossref
Crossref
James Chan & Theodore R Levin. (2004) Long-Term Drug Treatment of GERD. Disease Management & Health Outcomes 12:6, pages 399-407.
Crossref
Crossref
C. J. J. Mulder, B. D. Westerveld, J. M. Smit, M. Oudkerk Pool, M. H. Otten, T. G. Tan, A. W. M. van Milligen de Wit & G. H. de Groot. (2002) A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. European Journal of Gastroenterology & Hepatology 14:6, pages 649-656.
Crossref
Crossref
J. J. Ofman, G. H. Dorn, M. B. Fennerty & R. Fass. (2002) The clinical and economic impact of competing management strategies for gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 16:2, pages 261-273.
Crossref
Crossref
Vakil, Hahn & McSorley. (2000)
Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 14:1, pages 45-51.
Crossref
Crossref
Ziad Younes & David A. Johnson. (1999) DIAGNOSTIC EVALUATION IN GASTROESOPHAGEAL REFLUX DISEASE. Gastroenterology Clinics of North America 28:4, pages 809-830.
Crossref
Crossref
Lars Lundell & John Dent. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors
223
235
.
S. Bruley Des Varannes, Duquesnoy, Mamet, Slama, Galmiche & Scarpignato. (2001) Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans. Alimentary Pharmacology & Therapeutics 12:11, pages 1155-1161.
Crossref
Crossref
J. M. Lee & C. A. O'Morain. (1998) Trends in the management of gastro-oesophageal reflux disease.. Postgraduate Medical Journal 74:869, pages 145-150.
Crossref
Crossref
C. M. Bate, J. R. B. Green, A. T. R. Axon, F. E. Murray, G. Tildesley, C. E. Emmas & M. D. Taylor. (1997) Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis. Alimentary Pharmacology and Therapeutics 11:4, pages 755-763.
Crossref
Crossref
J.-P. Galmiche, P. Barthelemy & B. Hamelin. (1997) Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Alimentary Pharmacology and Therapeutics 11:4, pages 765-773.
Crossref
Crossref
R. Lambert. (1997) Current practice and future perspectives in the management of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 11:4, pages 651-662.
Crossref
Crossref
J. -P. Galmiche, M. Le Rhun & V. Papapietro. (1997) Nécessité, difficultés et pré-requis de la classification endoscopique des œsophagites. Acta Endoscopica 27:4, pages 287-288.
Crossref
Crossref
MI Maas, WP Hopman, T van der Wijk, MB Katan & JB Jansen. (1997) Sucrose polyester does not inhibit gastric acid secretion or stimulate cholecystokinin release in men. The American Journal of Clinical Nutrition 65:3, pages 761-765.
Crossref
Crossref
N. I. McDougall. (1996) Diagnosis of Reflux Disease. Irish Journal of Medical Science 165:3, pages 185-190.
Crossref
Crossref
K. Vanamo, R.J. Rintala, H. Lindahl & I. Louhimo. (1996) Long-term gastrointestinal morbidity in patients with congenital diaphragmatic defects. Journal of Pediatric Surgery 31:4, pages 551-554.
Crossref
Crossref